Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/09/2010 | US20100226910 Tissue kallikrein for the treatment of diseases associated with amyloid protein |
09/09/2010 | US20100226878 Methods of inhibiting photoreceptor apoptosis |
09/08/2010 | EP2226632A1 Method for screening of cell-protecting agent |
09/08/2010 | EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii |
09/08/2010 | EP2226315A1 2-aminoquinazoline derivative |
09/08/2010 | EP2226081A1 Peptide vaccine using mimic molecule of amyloid beta-peptide |
09/08/2010 | EP2226077A1 Use of an extract of Lycoris chejuenis and/or a compound isolated therefrom for preventing and/or treating a neurodegenerative disease |
09/08/2010 | EP2226074A2 Pharmaceutical compositions and their methods of use |
09/08/2010 | EP2225272A2 Novel peptides derived from ncam (fgls) |
09/08/2010 | EP2225245A2 N-phenyl-imidazoý1,2-a¨pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
09/08/2010 | EP2225244A1 Imidazoý1,2-a¨pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
09/08/2010 | EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/08/2010 | EP2225242A2 Derivatives of n-heterocyclic-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/08/2010 | EP2225241A2 Derivatives of n-phenyl-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/08/2010 | EP2225227A2 Compounds |
09/08/2010 | EP2225224A2 Novel hemioxalate salt of eletriptan |
09/08/2010 | EP2225223A2 Organic compounds |
09/08/2010 | EP2225212A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
09/08/2010 | EP2224930A1 Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
09/08/2010 | EP2224927A1 Pterin analog for treating bh4 responsive condition |
09/08/2010 | EP2224924A1 Compositions and methods for treating cystic fibrosis |
09/08/2010 | EP2224917A1 Compositions comprising nicotinic agonists and methods of using same |
09/08/2010 | EP2224808A2 Pharmaceutical composition |
09/08/2010 | EP1915357B1 2-hydroxy-propionic acid derivatives and 3-hydroxy-benzofuran-2-one derivatives with affinity for the gaba-b-receptor |
09/08/2010 | EP1478624B1 Chemical compounds |
09/08/2010 | EP1476171B1 Transportation of nucleic acid substances |
09/08/2010 | EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
09/08/2010 | EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
09/08/2010 | EP1263759B1 Azaindoles |
09/08/2010 | CN1943642B Preparing method for a kind of medicinal composition and its effective parts and active ingredients |
09/08/2010 | CN1939533B Injection sarcosine peptide aglycone powdery injection and its making method |
09/08/2010 | CN1899405B Mouth spray liquid for giving-up smoking and its preparing method |
09/08/2010 | CN1893926B Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents |
09/08/2010 | CN1882315B Solid pharmaceutical preparation form |
09/08/2010 | CN1778300B Luotongding oral cavity disintegration tablet and preparation thereof |
09/08/2010 | CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
09/08/2010 | CN1613482B Composition for improving memory |
09/08/2010 | CN101827864A Liquid formulation of G-CSF conjugate |
09/08/2010 | CN101827862A Humanized antibodies to Abeta(20-42) globulomer and uses thereof |
09/08/2010 | CN101827853A Heterocycle-substituted piperazino-dihydrothienopyrimidines |
09/08/2010 | CN101827843A Method for producing pyrazole fused ring derivative |
09/08/2010 | CN101827840A Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
09/08/2010 | CN101827839A 1,3,5-trisubstituted triazole derivative |
09/08/2010 | CN101827836A Trisubstituted 1,2,4-triazoles |
09/08/2010 | CN101827828A 1, 2, 4 -triazole derivatives as serotonergic modulators |
09/08/2010 | CN101827827A 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inhibitors |
09/08/2010 | CN101827826A 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
09/08/2010 | CN101827816A Therapeutic agent for TRPV1-mediated disease |
09/08/2010 | CN101827597A Treatment of sleep disorders |
09/08/2010 | CN101827594A Combination therapy for reducing side effects using cannabinoid receptor ligands |
09/08/2010 | CN101827592A Methods for treating post-operative effects such as spasticity and shivering with clonidine |
09/08/2010 | CN101827588A Novel nutraceutical compositions containing thymol and/or p-cymene or plant extracts for cognition |
09/08/2010 | CN101824399A Method for inducing and differentiating into dopaminergic neuron from human amniotic sepithelial cell and application for separating obtained dopaminergic neuron |
09/08/2010 | CN101824084A Targeting antiglioma protein and application thereof |
09/08/2010 | CN101824067A Barrigenol-type triterpenoid saponins compound, preparation method and application thereof |
09/08/2010 | CN101824030A Preparation method of Iloperidone |
09/08/2010 | CN101824012A 2-(1,6,7,8-tetrahydrogen-2H-indeno-[5,4-b] furan-8-group) acetonitrile, preparation method and applciation |
09/08/2010 | CN101823999A 1,3,5-trisubstituted 4,5 - dihydro - 1H - pyrazole derivatives having CB1 - antagonistic activity |
09/08/2010 | CN101823970A Synthetic method of rivastigmine and intermediates thereof |
09/08/2010 | CN101822841A Application of organic amine derivatives as brain-targeting modification group of small-molecule drug |
09/08/2010 | CN101822823A Fibrinogen-420 and new application of active structure domain thereof |
09/08/2010 | CN101822791A Medicinal broth for treating insomnia |
09/08/2010 | CN101822790A Prescription for treating insomnia |
09/08/2010 | CN101822784A Plaster for treating spur and preparation method thereof |
09/08/2010 | CN101822775A Traditional Chinese medicinal composition for treating insomnia |
09/08/2010 | CN101822768A Traditional Chinese medicine composition for treating epidemic encephalitis B |
09/08/2010 | CN101822760A Anti-senile dementia traditional Chinese medicine composite preparation and preparation process thereof |
09/08/2010 | CN101822748A Method for preparing medlar and rehmannia root wine |
09/08/2010 | CN101822692A Method for removing hemolytic toxicity from physaliatoxin |
09/08/2010 | CN101822676A Methods of treating patients suffering from movement disorders |
09/08/2010 | CN101822674A Iloperidone drug composition and preparation method thereof |
09/08/2010 | CN101822673A Iloperidone-containing solid medicinal composition |
09/08/2010 | CN101822466A Health-care mattress |
09/08/2010 | CN101822342A Method for preparing cortex albiziae porridge |
09/08/2010 | CN101822299A Method for preparing Albizia julibrissin tea |
09/08/2010 | CN101422460B Preparation method of FK506 slow-release film for repairing nerve damage |
09/08/2010 | CN101366705B Risperidone percutaneous absorption paster |
09/08/2010 | CN101361748B Use of ginsenoside in preparing medicine for treating infrasound impariment |
09/08/2010 | CN101317992B Traditional Chinese medicine preparation for treating senile dementia and preparation method thereof |
09/08/2010 | CN101278939B Medicament composition for curing cardiovascular and cerebrovascular diseases and method of preparing the same |
09/08/2010 | CN101269189B Chinese medicinal composition for treating sick headache |
09/08/2010 | CN101219164B Traditional Chinese medicine preparation for treating sick headache |
09/08/2010 | CN101181444B Multi-efficacy externally used drug as well as method for preparing immersion agent thereof |
09/08/2010 | CN101181267B Zolmitriptan tongue tablet |
09/08/2010 | CN101152349B Multifunctional health care medical pillow and its preparing process |
09/08/2010 | CN101134774B Combined chemical modified endomorphin-1 and method for preparing same |
09/08/2010 | CN101134041B Antidepressant and uses thereof |
09/08/2010 | CN101099740B Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
09/08/2010 | CN101057674B Composition for preventing and curing diabetes |
09/08/2010 | CN101053623B Medicinal composition for treating pain and preparation technology thereof |
09/08/2010 | CN101039911B Polymorph of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
09/08/2010 | CN101027297B Macrocyclic beta-secretase inhibitors |
09/08/2010 | CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation |
09/08/2010 | CN101011476B Traditional Chinese medicine composition for drug treatment |
09/07/2010 | US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
09/07/2010 | US7790854 antibody zeta -C2 raised against the sequence set forth in SEQ ID NO:2, which specifically binds to the atypical isoform protein kinase M zeta (PKM zeta ); Alzheimer's disease (AD) and neuroblastoma; using aPKC in diagnosis, drug screening and gene therapy |
09/07/2010 | US7790772 administering desmethylsertraline a monoamine reuptake inhibitor, for the treatment of brain disorders, behavioral disorders, eating disorders, disorders, sexual disorders, drug abuse and dependence, and for the prophylaxis of headaches |
09/07/2010 | US7790764 Biologically active macrolides, compositions, and uses thereof |
09/07/2010 | US7790761 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole |
09/07/2010 | US7790757 Administering a compound (2S)-(4E)-N-methyl-5-(5-isopropoxy-3-pyridyl-4-penten-2-amine; attention deficit disorder |